Teva Pharmaceutical Industries Limited American Depositary Shares (TEVA)
SG&A Expense Growth
3.40%
Quarterly · Period ending:
TEVA SG&A Expense Growth
Latest reported3.40%period ending
Latest reported3.40%period ending
TEVA Quarterly SG&A Growth (QoQ) (0.00% → 3.40%)
Latest values, visible window
High-resolution chart · PNG
TEVA sg&a expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 3.4% | |
| -10.7143% | |
| 15.1079% | |
| 1.4599% | |
| 4.3526% | |
| -3.4664% | |
| 3.0303% | |
| -1.5974% | |
| 5.9819% | |
| -1.7738% | |
| 6.872% | |
| -7.2527% | |
| 8.076% | |
| 0.5974% | |
| 1.8248% | |
| -9.3716% | |
| 3.0682% | |
| -3.0837% | |
| 2.2523% | |
| 3.6173% | |
| -2.0571% | |
| -13.3663% | |
| 14.2534% | |
| 2.6713% | |
| -6.1069% | |
| -10.5366% | |
| 16.4773% | |
| -8.5239% | |
| 2.3404% | |
| -17.6161% | |
| 8.4601% | |
| 2.5341% | |
| -6.7273% | |
| -18.9388% | |
| 14.0336% | |
| -3.4091% | |
| 2.0713% | |
| -16.1806% | |
| 15.2% | |
| -1.0293% | |
| 10.4987% | |
| -5.3024% | |
| 10.1277% | |
| -7.5105% | |
| -3.5801% | |
| -7.3152% | |
| 6.6774% | |
| 1.6353% | |
| -4.8989% | |
| -11.1878% | |
| 14.1956% | |
| -2.5365% | |
| -0.0768% | |
| -5.2402% | |
| 13.9303% | |
| -7.0162% | |
| 4.5968% | |
| -8.2161% | |
| 47.1678% | |
| -15.625% | |
| 3.3238% | |
| -2.4096% | |
| 9.3212% | |
| 18.4874% | |
| -10.8137% | |
| -3.7113% | |
| 9.8528% | |
| 4.3735% | |
| 5.75% | |
| 17.6471% | |
| 4.9383% | |
| -3.139% | |
| 30.1556% | |
| -0.7722% | |
| 13.1004% | |
| -2.3454% | |
| 2.8509% | |
| -4.4226% | |
| 18.1526% | |
| 7.5366% | |
| 18.9797% | |
| 45.1034% | |
| 1.6355% | |
| 17.1319% | |
| -1.0293% | |
| -1.7563% | |
| 3.5262% | |
| 7.3964% | |
| 6.8944% | |
| 10.7919% | |
| 13.8867% | |
| -3.5412% | |
| 5.868% | |
| 17.8674% | |
| -3.9668% | |
| 9.8278% | |
| 3.6765% | |
| -3.413% | |
| 17.0594% | |
| -7.2452% |